XML 133 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Business Combinations (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Apr. 01, 2022
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Jun. 06, 2023
Mar. 01, 2023
Jun. 16, 2022
$ / shares
Feb. 18, 2022
USD ($)
Business Combinations [Line Items]              
Common stock par value (in Dollars per share) | $ / shares [1]   $ 0.0001 $ 0.0001        
Warrants purchased   7,028,337          
Common stock, shares issued [1]   77,451,000 55,963,000        
Common stock shares QPhoton warrants   36,600,823          
Net of cash acquired (in Dollars) | $ [2]   $ 1,356        
Exercise price (in Dollars per share) | $ / shares   $ 2.27          
Principal balance (in Dollars) | $ $ 1,250            
Loans assumed (in Dollars) | $ $ 2,500            
Percentage of interest rate 15.00%           6.00%
Extension year         1 year    
Patented Technology [Member]              
Business Combinations [Line Items]              
Fair value of attributable to technology and licensed patents (in Dollars) | $   $ 12,700          
Purchase Agreement [Member]              
Business Combinations [Line Items]              
Promissory note principal amount (in Dollars) | $             $ 1,250
Warrant [Member]              
Business Combinations [Line Items]              
Warrants purchased   7,028,337          
Common stock shares QPhoton warrants   6,325,503 6,325,503        
Maximum [Member]              
Business Combinations [Line Items]              
Stock conversion ratio   10          
Percentage of interest rate       15.00%      
Minimum [Member]              
Business Combinations [Line Items]              
Stock conversion ratio   1          
Percentage of interest rate       10.00%      
Non-Compete Agreement [Member]              
Business Combinations [Line Items]              
Fair value (in Dollars) | $   $ 3,250          
Common Stock [Member]              
Business Combinations [Line Items]              
Share price (in Dollars per share) | $ / shares           $ 2.27  
QPhoton [Member]              
Business Combinations [Line Items]              
Warrants purchased   1,726,931          
Common stock shares QPhoton warrants   6,325,503          
Converted shares   31,299,417          
Fair value of attributable to trade name and trademark (in Dollars) | $   $ 1,000          
Principal balance (in Dollars) | $             $ 1,250
Common Stock [Member]              
Business Combinations [Line Items]              
Common stock, shares issued   32,940,738 32,940,738        
Common stock shares QPhoton warrants   26,615,235          
Converted shares   36,600,823          
Common Stock [Member] | Warrant [Member]              
Business Combinations [Line Items]              
Converted shares   7,028,337          
Common Stock [Member] | Merger with QPhoton, Inc. [Member]              
Business Combinations [Line Items]              
Consideration of common shares   5,802,206          
Common stock par value (in Dollars per share) | $ / shares   $ 0.0001          
Common stock, shares issued   36,600,823          
Series B Preferred Stock [Member]              
Business Combinations [Line Items]              
Converts shares   10          
Purchase price approximately (in Dollars) | $   $ 71,000          
Net of cash acquired (in Dollars) | $   $ 69,900          
Converted shares   2,377,028          
Series B Preferred Stock [Member] | Merger with QPhoton, Inc. [Member]              
Business Combinations [Line Items]              
Preferred stock shares issued   2,377,028          
Preferred stock, par value (in Dollars per share) | $ / shares   $ 0.0001          
Series B Preferred Stock [Member] | QPhoton [Member]              
Business Combinations [Line Items]              
Warrants purchased   1,726,931          
[1] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.
[2] As described in Note 3 to the Consolidated Financial Statements appearing elsewhere in this Amendment, we have restated the Consolidated Financial Statements.